Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting
Cancer Medicine · 2023-03 · 12 (6) · 7189-7206
DOI: 10.1002/cam4.5491 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 10.02.2023. Verfasst von Xiaofeng Dai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi School of Medicine, Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Neoplasms, Mesenchymal Stem Cells, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
With mounting preclinical and clinical evidences on the prominent roles of the tumor microenvironment (TME) played during carcinogenesis, the TME has been recognized and used as an important onco‐therapeutic target during the past decade. Delineating our current knowledge on TME components and their functionalities can help us recognize novel onco‐therapeutic opportunities and establish treatment modalities towards desirable anti‐cancer outcome. By identifying and focusing on primary cellular components in the TME, that is, tumor‐infiltrating lymphocytes, tumor‐associated macrophages, cancer‐associated fibroblasts and mesenchymal stem cells, we decomposed their primary functionalities during carcinogenesis, categorized current therapeutic approaches utilizing traits of these components, and forecasted possible benefits that cold atmospheric plasma, a redox modulating tool with selectivity against cancer cells, may convey by targeting the TME. Our insights may open a novel therapeutic avenue for cancer control taking advantages of redox homeostasis and immunostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wuxi School of Medicine, Jiangnan University, Wuxi, China.
- Affiliated Hospital of Jiangnan University, Wuxi, China.
ORCID-Profile: Xiaofeng Dai, Kaiyuan Zhu
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Dai, X., & Zhu, K. (2023). Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting. Cancer Medicine, 12(6), 7189-7206. https://doi.org/10.1002/cam4.5491
Vancouver
Dai X, Zhu K. Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting. Cancer Medicine. 2023;12(6):7189-7206. doi:10.1002/cam4.5491
BibTeX
@article{Dai2023,
author = {Dai, Xiaofeng and Zhu, Kaiyuan},
title = {Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {6},
pages = {7189--7206},
doi = {10.1002/cam4.5491}
}
EUVIMED